A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy

Clinical trial NCT07483827 · RECRUITING

Trial details

NCT number: NCT07483827
Sponsor: eleva GmbH
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

C3 Glomerulopathy (C3G)Healthy Adult Participants

Start date: 2025-06-26
Primary completion: 2026-11-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.